03.03.2022 - Phase 3 ENHANCE program on track to report top-line COPD data in 2022 Conference call today at 9:00 a.m. EST / 2:00 p.m. GMT LONDON and RALEIGH, N.C., March 03, 2022 (GLOBE NEWSWIRE) - Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the .
/PRNewswire/ Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the.
THE HAGUE, Netherlands, Jan. 19, 2022 /PRNewswire/ Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces
/PRNewswire/ Amber Implants, an innovative medical technology company developing next generation spinal implants for spinal injuries, today announces the.